| Primary |
| Colonoscopy |
25.0% |
| Drug Use For Unknown Indication |
25.0% |
| Bowel Preparation |
16.7% |
| Hypertension |
12.5% |
| Product Used For Unknown Indication |
12.5% |
| Constipation |
8.3% |
|
| Renal Failure Chronic |
19.0% |
| Vomiting |
14.3% |
| Syncope |
9.5% |
| Contraindication To Medical Treatment |
4.8% |
| Hypocalcaemia |
4.8% |
| Hypomagnesaemia |
4.8% |
| Intracardiac Thrombus |
4.8% |
| Paraesthesia Oral |
4.8% |
| Peritonitis |
4.8% |
| Renal Disorder |
4.8% |
| Renal Failure Acute |
4.8% |
| Renal Impairment |
4.8% |
| Somnolence |
4.8% |
| Toxicity To Various Agents |
4.8% |
| Urinary Tract Infection |
4.8% |
|
| Secondary |
| Parenteral Nutrition |
54.2% |
| Constipation |
16.7% |
| Colonoscopy |
4.2% |
| Diabetes Mellitus |
4.2% |
| Major Depression |
4.2% |
| Oedema Peripheral |
4.2% |
| Pain |
4.2% |
| Type 2 Diabetes Mellitus |
4.2% |
| Vomiting |
4.2% |
|
| Renal Failure Acute |
50.0% |
| Urinary Retention |
25.0% |
| Weight Decreased |
25.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.7% |
| Adverse Event |
16.5% |
| Drug Use For Unknown Indication |
15.2% |
| Pain |
5.6% |
| Prophylaxis |
3.7% |
| Acute Myeloid Leukaemia |
2.6% |
| Constipation |
2.5% |
| Nausea |
2.3% |
| Mantle Cell Lymphoma |
1.7% |
| Premedication |
1.5% |
| Breakthrough Pain |
1.4% |
| Hypertension |
1.4% |
| Prostate Cancer |
1.3% |
| Vomiting |
1.3% |
| Neoplasm Malignant |
1.2% |
| Supplementation Therapy |
1.2% |
| Depression |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Vitamin Supplementation |
0.9% |
| Acute Lymphocytic Leukaemia |
0.8% |
|
| Pneumonia |
11.4% |
| Cardiac Arrest |
10.0% |
| Vomiting |
10.0% |
| Ventricular Tachycardia |
7.1% |
| Dehydration |
5.7% |
| Grand Mal Convulsion |
5.7% |
| Febrile Neutropenia |
4.3% |
| Pyrexia |
4.3% |
| Renal Failure |
4.3% |
| Sepsis |
4.3% |
| Septic Shock |
4.3% |
| Weight Increased |
4.3% |
| White Blood Cell Count Increased |
4.3% |
| Failure To Thrive |
2.9% |
| Haemoglobin Decreased |
2.9% |
| Hypotension |
2.9% |
| Intestinal Obstruction |
2.9% |
| Necrotising Colitis |
2.9% |
| Neutropenic Colitis |
2.9% |
| Pain In Extremity |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
85.7% |
| Colonoscopy |
14.3% |
|
| Renal Failure Acute |
100.0% |
|
